Peringkat dalam Saham
#16843
Oryzon Genomics S.A., a clinical stage biopharmaceutical company, engages in... Oryzon Genomics S.A., a clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS (central nervous system), oncology, and hematology disorders. Its clinical phase compounds include iadademstat (ORY-1001), a selective LSD1 inhibitor that is in Phase II trials for oncology; and vafidemstat (ORY-2001), a CNS-optimized LSD1 inhibitor, which is in Phase II trials for the treatment of CNS and psychiatric diseases. Its product candidates also comprise ORY-3001, an LSD1 inhibitor that is in preclinical development for the treatment of non-oncological diseases; and ORY-4001, a selective HDAC-6 inhibitor for the treatment of neurological disorders, such as Charcot-Marie-Tooth disease (CMT), amyotrophic lateral sclerosis (ALS), and others. It also has collaborations in precision medicine with Columbia University in New York and the Institute of Medical and Molecular Genetics (INGEMM) at La Paz Hospital in Madrid psychometrically characterize patients with mutations in the SetD1A or Shank3 genes; and Cooperative Research and Development Agreement (CRADA) to sponsor several clinical trials. The company was incorporated in 2000 and is based in Cornellà de Llobregat, Spain.
Harga Saham
$3.31
Terakhir disinkronkan: 2026-09-01
Kapitalisasi Pasar
$271.03M
Perubahan (1 hari)
-0.36%
Perubahan (1 tahun)
8.04%
Perdagangan Oryzon Genomics S.A. (ORY)
Harga ORY dengan kapitalisasi pasar B
Kapitalisasi pasar dari Oryzon Genomics S.A.(ORY)
Kapitalisasi Pasar: $271.03M
Per September 2026, Oryzon Genomics S.A. memiliki kapitalisasi pasar sebesar $271.03M. Ini menjadikan Oryzon Genomics S.A. sebagai perusahaan 16843rd paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Oryzon Genomics S.A. dari 2015 hingga 2026
ORY dibandingkan dengan 5 teratas stocks paling populer
| Harga ORY |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.260T
|
+1,940,475.84%
|
|
|
|
|
$4.779T
|
+1,762,978.10%
|
|
|
|
|
$4.017T
|
+1,481,909.34%
|
|
|
|
|
$3.719T
|
+1,372,169.56%
|
|
|
|
|
$2.734T
|
+1,008,720.02%
|
